NCT06810193

Brief Summary

The purpose of this Phase 2, double-arm study is to identify repetitive, non-concussive head impacts that impair neurologic functioning, and to test treatments that can mitigate these effects and return functioning to normal as quickly as possible.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
43mo left

Started Jul 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jul 2025Dec 2029

First Submitted

Initial submission to the registry

January 25, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

July 23, 2025

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

4.4 years

First QC Date

January 25, 2025

Last Update Submit

September 9, 2025

Conditions

Keywords

Repetitive Head Impacts

Outcome Measures

Primary Outcomes (10)

  • Optical Coherence Tomography (OCT) of Cerebrospinal Fluid Thickness in the Macula (Part of the Retina)

    A primary OCT variables examined will be macula cerebrospinal fluid (CSF) thickness (an indicator of the gain or loss of neurons or glia in the inner nuclear, ganglion cell and nerve fiber layer).

    Pre-season and post-season, 2 weeks

  • Change in Blood Serum Concentrations of Glial Fibrillary Acidic Protein (GFAP)

    Glial Fibrillary Acidic Protein (GFAP) concentration will determine if there is a 11.9 pg/mL or greater change in GFAP in each participant over the course of the study.

    Baseline 4 to 7 months

  • Change in Blood Serum Concentration of Neurofilament light chain (NfL) in a blood sample

    The neurologic test battery consists of blood draws for serum brain proteins: Neurofilament light chain (NfL) concentrations will be observed for changes over the course of the study.

    Baseline 4 to 7 months

  • Change in p-231Tau serum concentration in a blood sample

    The neurologic test battery consists of blood draws for serum brain proteins: p231Tau will be observed for changes over the course of the study.

    Baseline 4 to 7 months

  • Change in Concussion Index as measured with Quantitative Electroencephalogram (qEEG)

    The Quantitative Electroencephalogram (qEEG) Concussion Index (CI) includes measures of power (absolute and relative), mean frequency, connectivity (asymmetry, coherence, phase lag, phase synchrony), complexity (fractal dimension and scale-free activity), and information theory (entropy), across and within frequency bands.

    Baseline 4 to 7 months

  • Change in near-point convergence (NPC)

    Near point of convergence (NPC) is a measurement of how close an object can be brought to the eyes while the eyes are focused on it.

    Baseline 4 to 7 months

  • Change in Choice reaction time (CRT)

    Choice reaction time (CRT) refers to the time it takes for a person to react to a stimulus by selecting a specific response from multiple options.

    Baseline 4 to 7 months

  • Change in blink reflex test

    A blink reflex test, also known as a corneal reflex test, is a non-invasive procedure that measures the electrical activity of the facial nerves when stimulated.

    Baseline 4 to 7 months

  • Optical Coherence Tomography (OCT) to detect signs of neurodegenertaion in the Retina

    OCT will be used to measure the cup-to-disc ratio of the optic disc, and indicator of neurodegeneration.

    Pre-season and post-season, 2 weeks

  • Optical Coherence Tomography/Angiography (OCT/A) to assess the vascular structure in the retina

    Retinal vascular structure will be acquired using the OCT angiography (OCT/A). The primary OCT/A variable examined will be foveal avascular zone (FAZ) area reflecting the size of the central portion of the macula which contains no blood vessels, and which increases in size with loss of capillaries in the surrounding region).

    Pre-season and post-season, 2 weeks

Study Arms (2)

Observational (Ad-Lib Exercise) Arm

NO INTERVENTION

All participants will undergo neurologic outcome testing with optical coherence tomography/angiography (OCT/A) at pre- and post-season and 2 weeks after the end of the season. For two weeks at the end of the sport season, participants will be instructed to refrain from sports involving head contact but to otherwise exercise ad-lib.

Intervention (Exercise or Stretching) Arm

EXPERIMENTAL

Athletes and athlete cadets will be administered OCT/A and a novel neurologic test battery at pre- and post-season, and 2 weeks after the end of the season. After the end-of-season assessments, participants will be randomized to 2 weeks of either 30 minutes of daily aerobic exercise or to 30-minutes of prescribed stretching.

Other: Aerobic exercise

Interventions

After the end-of-season assessments, participants in the Intervention (Exercise or Stretching) arm will be randomized to 2 weeks of daily aerobic exercise for 30 minutes or to 30-minutes of prescribed stretching.

Intervention (Exercise or Stretching) Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Collegiate athlete or athlete-cadet anticipated to be an active member of a varsity sport team.

You may not qualify if:

  • Any head, neck, or face injury in the 3 months prior to enrollment that precludes participation in contact sports or wearing a mouth guard sensor
  • History of neurological or psychiatric disorders or neurological disorders that impact electrical activity in the brain (such as seizure disorders), or diagnosed learning disability, that in the opinion of the investigator, would interfere with participation in the study.
  • Participants currently undergoing active treatment for migraine, depression and/or anxiety or ADHD will not be excluded as these are high prevalence conditions in the adolescent and collegiate population (8-30%). However, exploratory stratified analyses will be conducted where possible.
  • Participants with eye conditions or diseases that could impact the blood vessels in the eye.
  • Determination that the participant is unsuitable for study entry or potentially unable to complete all aspects of the study based on the judgement of the Site Investigator or Study PI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University at Buffalo

Amherst, New York, 14221, United States

Location

University of Rochester

Rochester, New York, 14620, United States

Location

The Citadel, The Military College of South Carolina

Charleston, South Carolina, 29409, United States

Location

MeSH Terms

Conditions

Craniocerebral Trauma

Interventions

Exercise

Condition Hierarchy (Ancestors)

Trauma, Nervous SystemNervous System DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 25, 2025

First Posted

February 5, 2025

Study Start

July 23, 2025

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

December 1, 2029

Last Updated

September 11, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations